Polydeoxyribonucleotide (PDRN) for Cuff Regeneration

PHASE4CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

May 9, 2019

Primary Completion Date

August 9, 2021

Study Completion Date

February 22, 2022

Conditions
Rotator Cuff Tear
Interventions
DRUG

Polydeoxyribonucleotides

Just after arthroscopic rotator cuff repair, 3cc polydeoxyribonucleotide will be injected, and 2 weeks after the surgery the same amount of the material will be injected.

DRUG

Normal saline

Just after arthroscopic rotator cuff repair, 3cc normal saline will be injected, and 2 weeks after the surgery the same amount of the material will be injected.

Trial Locations (1)

24253

Chuncheon Sacred Heart Hospital, Chuncheon

All Listed Sponsors
collaborator

Ministry of Science and ICT, Republic of Korea

OTHER_GOV

lead

Chuncheon Sacred Heart Hospital

OTHER

NCT03916198 - Polydeoxyribonucleotide (PDRN) for Cuff Regeneration | Biotech Hunter | Biotech Hunter